T1	HMM 1032 1064	including cough and bronchospasm
T2	HMM 1073 1095	and progression of PAH
T3	HMM 1101 1104	1).
T4	HMM 1105 1138	Mild side effects including cough
T5	HMM 1147 1162	and sore throat
T6	HMM 1206 1214	therapy.
T7	HMM 1215 1257	World Health Organization functional class
T8	HMM 1294 1315	10; exercise capacity
T9	HMM 1434 1467	0.01) and peak oxygen consumption
T10	HMM 1579 1652	improvement in exercise capacity and World Health Organization functional
